BRIGATINIB SHOWS PRECLINICAL PROMISE FOR AGGRESSIVE RELAPSED/REFRACTORY AK = LK-POSITIVE ALCL. (October 2022) - Matthews, J.; Prokoph, N.; Trigg, R.; Montes-Mojarro, I.; Fend, F.; Kenner, L.; Geoerger, B.; Johnston, R.; Murray, M.; Brugières, L.; Burke, A.; Turner, Suzanne D